Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia
The outcome of cardiac sarcoidosis is sometimes very poor. Ventricular tachycardia (VT) associated with cardiac sarcoidosis is the most common cause of sudden death among most patients. However, there is no established method for potential VT in patients with cardiac sarcoidosis. Thus, we investigat...
Gespeichert in:
| Veröffentlicht in: | International Journal of Cardiovascular Imaging 2006-06, Vol.22 (3-4), p.443-448 |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 448 |
|---|---|
| container_issue | 3-4 |
| container_start_page | 443 |
| container_title | International Journal of Cardiovascular Imaging |
| container_volume | 22 |
| creator | Futamatsu, Hideki Suzuki, Jun-ichi Adachi, Susumu Okada, Hiroyuki Otomo, Kenichiro Ohara, Takahiro Hashimoto, Yuji Kakuta, Tsunekazu Iesaka, Yoshito Yamaguchi, Hiroaki Sakurada, Harumizu Sato, Akira Obayashi, Tohru Niwa, Akihiro Hirao, Kenzo Isobe, Mitsuaki |
| description | The outcome of cardiac sarcoidosis is sometimes very poor. Ventricular tachycardia (VT) associated with cardiac sarcoidosis is the most common cause of sudden death among most patients. However, there is no established method for potential VT in patients with cardiac sarcoidosis. Thus, we investigated the utility of evaluation of gallium-67 scintigraphy for potential VT in patients with cardiac sarcoidosis.
Cardiac sarcoidosis was diagnosed in 25 patients at ours or collaborating hospitals during the period 1982 through 2004. Twenty-one of these patients were treated with corticosteroid, and these patients were divided into two groups, depending on whether VT was present: a non-VT group (n=7) and a VT group (n=14). Laboratory and gallium-67 scintigraphy findings were examined in both groups. During the follow-up period, initial and maintenance dosages of corticosteroid did not differ significantly between the groups. Accumulation of gallium-67 in the heart at the time of diagnosis was detected more frequently in the VT group than in the non-VT group (14.3 vs. 71.4%, p |
| doi_str_mv | 10.1007/s10554-005-9043-x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68051658</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1063783071</sourcerecordid><originalsourceid>FETCH-LOGICAL-c383t-50e5b4790b9ce38edb0fa84885e48801538c6368897df363e069e70649d779fa3</originalsourceid><addsrcrecordid>eNqFkU1PGzEQhq0KxEfgB_RSWRx6cxmvv48oolApUi_lbDleLzHarFPbG8i_Z6NEQuLCZWYOzzvSzIPQdwq_KIC6LRSE4ARAEAOckbdv6IIKxQgozk72szREKMPP0WUpLwBUMWPO0DmVSjKt-QUKTzX2se5w6vCz6_s4rolUuPg41Pic3Wa1w13KOGxdP7oa07AnvcttdB4Xl32KbSqx4NdYV3gbhpqjH3uXcXV-tTuQV-i0c30J18c-Q0-_7__NH8ni78Of-d2CeKZZJQKCWHJlYGl8YDq0S-ic5lqLMBWggmkvmdTaqLZjkgWQJiiQ3LRKmc6xGfp52LvJ6f8YSrXrWHzoezeENBYrNQgqhf4SbKBhXEk6gTefwJc05mE6wjbTexvNGz5B9AD5nErJobObHNcu7ywFuzdlD6bsZMruTdm3KfPjuHhcrkP7kTiqYe-Qr48F</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>215628424</pqid></control><display><type>article</type><title>Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia</title><source>MEDLINE</source><source>Springer Nature</source><creator>Futamatsu, Hideki ; Suzuki, Jun-ichi ; Adachi, Susumu ; Okada, Hiroyuki ; Otomo, Kenichiro ; Ohara, Takahiro ; Hashimoto, Yuji ; Kakuta, Tsunekazu ; Iesaka, Yoshito ; Yamaguchi, Hiroaki ; Sakurada, Harumizu ; Sato, Akira ; Obayashi, Tohru ; Niwa, Akihiro ; Hirao, Kenzo ; Isobe, Mitsuaki</creator><creatorcontrib>Futamatsu, Hideki ; Suzuki, Jun-ichi ; Adachi, Susumu ; Okada, Hiroyuki ; Otomo, Kenichiro ; Ohara, Takahiro ; Hashimoto, Yuji ; Kakuta, Tsunekazu ; Iesaka, Yoshito ; Yamaguchi, Hiroaki ; Sakurada, Harumizu ; Sato, Akira ; Obayashi, Tohru ; Niwa, Akihiro ; Hirao, Kenzo ; Isobe, Mitsuaki</creatorcontrib><description>The outcome of cardiac sarcoidosis is sometimes very poor. Ventricular tachycardia (VT) associated with cardiac sarcoidosis is the most common cause of sudden death among most patients. However, there is no established method for potential VT in patients with cardiac sarcoidosis. Thus, we investigated the utility of evaluation of gallium-67 scintigraphy for potential VT in patients with cardiac sarcoidosis.
Cardiac sarcoidosis was diagnosed in 25 patients at ours or collaborating hospitals during the period 1982 through 2004. Twenty-one of these patients were treated with corticosteroid, and these patients were divided into two groups, depending on whether VT was present: a non-VT group (n=7) and a VT group (n=14). Laboratory and gallium-67 scintigraphy findings were examined in both groups. During the follow-up period, initial and maintenance dosages of corticosteroid did not differ significantly between the groups. Accumulation of gallium-67 in the heart at the time of diagnosis was detected more frequently in the VT group than in the non-VT group (14.3 vs. 71.4%, p<0.05). Six of the seven VT patients who underwent follow-up examination showed improvement on the scintigram obtained after treatment. Five of the six showed no VT recurrence in terms of Holter electrocardiogram, electrophysiologic study, or delivery of implantable cardioverter defibrillator shock. Serum angiotensin-converting enzyme and lysozyme concentrations were within normal limits in most patients in both groups.
Activity of sarcoid granulomas may be associated with the occurrence of VT. Gallium-67 scintigraphy reflects the activity of sarcoid granulomas and thus is useful for evaluation of cardiac sarcoidosis in patients with potential VT.</description><identifier>ISSN: 1569-5794</identifier><identifier>EISSN: 1573-0743</identifier><identifier>DOI: 10.1007/s10554-005-9043-x</identifier><identifier>PMID: 16763884</identifier><identifier>CODEN: IJCIBI</identifier><language>eng</language><publisher>United States: Springer Nature B.V</publisher><subject>Adrenal Cortex Hormones - therapeutic use ; Amiodarone - therapeutic use ; Anti-Arrhythmia Agents - therapeutic use ; Anti-Inflammatory Agents - therapeutic use ; Cardiomyopathies - complications ; Cardiomyopathies - diagnostic imaging ; Cardiomyopathies - drug therapy ; Evaluation Studies as Topic ; Female ; Gallium Radioisotopes ; Humans ; Male ; Middle Aged ; Radionuclide Imaging ; Radiopharmaceuticals ; Retrospective Studies ; Sarcoidosis - complications ; Sarcoidosis - diagnostic imaging ; Sarcoidosis - drug therapy ; Tachycardia, Ventricular - diagnostic imaging ; Tachycardia, Ventricular - drug therapy ; Tachycardia, Ventricular - etiology ; Treatment Outcome</subject><ispartof>International Journal of Cardiovascular Imaging, 2006-06, Vol.22 (3-4), p.443-448</ispartof><rights>Springer Science+Business Media, Inc. 2006</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c383t-50e5b4790b9ce38edb0fa84885e48801538c6368897df363e069e70649d779fa3</citedby><cites>FETCH-LOGICAL-c383t-50e5b4790b9ce38edb0fa84885e48801538c6368897df363e069e70649d779fa3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16763884$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Futamatsu, Hideki</creatorcontrib><creatorcontrib>Suzuki, Jun-ichi</creatorcontrib><creatorcontrib>Adachi, Susumu</creatorcontrib><creatorcontrib>Okada, Hiroyuki</creatorcontrib><creatorcontrib>Otomo, Kenichiro</creatorcontrib><creatorcontrib>Ohara, Takahiro</creatorcontrib><creatorcontrib>Hashimoto, Yuji</creatorcontrib><creatorcontrib>Kakuta, Tsunekazu</creatorcontrib><creatorcontrib>Iesaka, Yoshito</creatorcontrib><creatorcontrib>Yamaguchi, Hiroaki</creatorcontrib><creatorcontrib>Sakurada, Harumizu</creatorcontrib><creatorcontrib>Sato, Akira</creatorcontrib><creatorcontrib>Obayashi, Tohru</creatorcontrib><creatorcontrib>Niwa, Akihiro</creatorcontrib><creatorcontrib>Hirao, Kenzo</creatorcontrib><creatorcontrib>Isobe, Mitsuaki</creatorcontrib><title>Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia</title><title>International Journal of Cardiovascular Imaging</title><addtitle>Int J Cardiovasc Imaging</addtitle><description>The outcome of cardiac sarcoidosis is sometimes very poor. Ventricular tachycardia (VT) associated with cardiac sarcoidosis is the most common cause of sudden death among most patients. However, there is no established method for potential VT in patients with cardiac sarcoidosis. Thus, we investigated the utility of evaluation of gallium-67 scintigraphy for potential VT in patients with cardiac sarcoidosis.
Cardiac sarcoidosis was diagnosed in 25 patients at ours or collaborating hospitals during the period 1982 through 2004. Twenty-one of these patients were treated with corticosteroid, and these patients were divided into two groups, depending on whether VT was present: a non-VT group (n=7) and a VT group (n=14). Laboratory and gallium-67 scintigraphy findings were examined in both groups. During the follow-up period, initial and maintenance dosages of corticosteroid did not differ significantly between the groups. Accumulation of gallium-67 in the heart at the time of diagnosis was detected more frequently in the VT group than in the non-VT group (14.3 vs. 71.4%, p<0.05). Six of the seven VT patients who underwent follow-up examination showed improvement on the scintigram obtained after treatment. Five of the six showed no VT recurrence in terms of Holter electrocardiogram, electrophysiologic study, or delivery of implantable cardioverter defibrillator shock. Serum angiotensin-converting enzyme and lysozyme concentrations were within normal limits in most patients in both groups.
Activity of sarcoid granulomas may be associated with the occurrence of VT. Gallium-67 scintigraphy reflects the activity of sarcoid granulomas and thus is useful for evaluation of cardiac sarcoidosis in patients with potential VT.</description><subject>Adrenal Cortex Hormones - therapeutic use</subject><subject>Amiodarone - therapeutic use</subject><subject>Anti-Arrhythmia Agents - therapeutic use</subject><subject>Anti-Inflammatory Agents - therapeutic use</subject><subject>Cardiomyopathies - complications</subject><subject>Cardiomyopathies - diagnostic imaging</subject><subject>Cardiomyopathies - drug therapy</subject><subject>Evaluation Studies as Topic</subject><subject>Female</subject><subject>Gallium Radioisotopes</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Radionuclide Imaging</subject><subject>Radiopharmaceuticals</subject><subject>Retrospective Studies</subject><subject>Sarcoidosis - complications</subject><subject>Sarcoidosis - diagnostic imaging</subject><subject>Sarcoidosis - drug therapy</subject><subject>Tachycardia, Ventricular - diagnostic imaging</subject><subject>Tachycardia, Ventricular - drug therapy</subject><subject>Tachycardia, Ventricular - etiology</subject><subject>Treatment Outcome</subject><issn>1569-5794</issn><issn>1573-0743</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkU1PGzEQhq0KxEfgB_RSWRx6cxmvv48oolApUi_lbDleLzHarFPbG8i_Z6NEQuLCZWYOzzvSzIPQdwq_KIC6LRSE4ARAEAOckbdv6IIKxQgozk72szREKMPP0WUpLwBUMWPO0DmVSjKt-QUKTzX2se5w6vCz6_s4rolUuPg41Pic3Wa1w13KOGxdP7oa07AnvcttdB4Xl32KbSqx4NdYV3gbhpqjH3uXcXV-tTuQV-i0c30J18c-Q0-_7__NH8ni78Of-d2CeKZZJQKCWHJlYGl8YDq0S-ic5lqLMBWggmkvmdTaqLZjkgWQJiiQ3LRKmc6xGfp52LvJ6f8YSrXrWHzoezeENBYrNQgqhf4SbKBhXEk6gTefwJc05mE6wjbTexvNGz5B9AD5nErJobObHNcu7ywFuzdlD6bsZMruTdm3KfPjuHhcrkP7kTiqYe-Qr48F</recordid><startdate>20060601</startdate><enddate>20060601</enddate><creator>Futamatsu, Hideki</creator><creator>Suzuki, Jun-ichi</creator><creator>Adachi, Susumu</creator><creator>Okada, Hiroyuki</creator><creator>Otomo, Kenichiro</creator><creator>Ohara, Takahiro</creator><creator>Hashimoto, Yuji</creator><creator>Kakuta, Tsunekazu</creator><creator>Iesaka, Yoshito</creator><creator>Yamaguchi, Hiroaki</creator><creator>Sakurada, Harumizu</creator><creator>Sato, Akira</creator><creator>Obayashi, Tohru</creator><creator>Niwa, Akihiro</creator><creator>Hirao, Kenzo</creator><creator>Isobe, Mitsuaki</creator><general>Springer Nature B.V</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>M7Z</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7QO</scope><scope>7X8</scope></search><sort><creationdate>20060601</creationdate><title>Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia</title><author>Futamatsu, Hideki ; Suzuki, Jun-ichi ; Adachi, Susumu ; Okada, Hiroyuki ; Otomo, Kenichiro ; Ohara, Takahiro ; Hashimoto, Yuji ; Kakuta, Tsunekazu ; Iesaka, Yoshito ; Yamaguchi, Hiroaki ; Sakurada, Harumizu ; Sato, Akira ; Obayashi, Tohru ; Niwa, Akihiro ; Hirao, Kenzo ; Isobe, Mitsuaki</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c383t-50e5b4790b9ce38edb0fa84885e48801538c6368897df363e069e70649d779fa3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Adrenal Cortex Hormones - therapeutic use</topic><topic>Amiodarone - therapeutic use</topic><topic>Anti-Arrhythmia Agents - therapeutic use</topic><topic>Anti-Inflammatory Agents - therapeutic use</topic><topic>Cardiomyopathies - complications</topic><topic>Cardiomyopathies - diagnostic imaging</topic><topic>Cardiomyopathies - drug therapy</topic><topic>Evaluation Studies as Topic</topic><topic>Female</topic><topic>Gallium Radioisotopes</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Radionuclide Imaging</topic><topic>Radiopharmaceuticals</topic><topic>Retrospective Studies</topic><topic>Sarcoidosis - complications</topic><topic>Sarcoidosis - diagnostic imaging</topic><topic>Sarcoidosis - drug therapy</topic><topic>Tachycardia, Ventricular - diagnostic imaging</topic><topic>Tachycardia, Ventricular - drug therapy</topic><topic>Tachycardia, Ventricular - etiology</topic><topic>Treatment Outcome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Futamatsu, Hideki</creatorcontrib><creatorcontrib>Suzuki, Jun-ichi</creatorcontrib><creatorcontrib>Adachi, Susumu</creatorcontrib><creatorcontrib>Okada, Hiroyuki</creatorcontrib><creatorcontrib>Otomo, Kenichiro</creatorcontrib><creatorcontrib>Ohara, Takahiro</creatorcontrib><creatorcontrib>Hashimoto, Yuji</creatorcontrib><creatorcontrib>Kakuta, Tsunekazu</creatorcontrib><creatorcontrib>Iesaka, Yoshito</creatorcontrib><creatorcontrib>Yamaguchi, Hiroaki</creatorcontrib><creatorcontrib>Sakurada, Harumizu</creatorcontrib><creatorcontrib>Sato, Akira</creatorcontrib><creatorcontrib>Obayashi, Tohru</creatorcontrib><creatorcontrib>Niwa, Akihiro</creatorcontrib><creatorcontrib>Hirao, Kenzo</creatorcontrib><creatorcontrib>Isobe, Mitsuaki</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central UK/Ireland</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Biochemistry Abstracts 1</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>Biotechnology Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>International Journal of Cardiovascular Imaging</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Futamatsu, Hideki</au><au>Suzuki, Jun-ichi</au><au>Adachi, Susumu</au><au>Okada, Hiroyuki</au><au>Otomo, Kenichiro</au><au>Ohara, Takahiro</au><au>Hashimoto, Yuji</au><au>Kakuta, Tsunekazu</au><au>Iesaka, Yoshito</au><au>Yamaguchi, Hiroaki</au><au>Sakurada, Harumizu</au><au>Sato, Akira</au><au>Obayashi, Tohru</au><au>Niwa, Akihiro</au><au>Hirao, Kenzo</au><au>Isobe, Mitsuaki</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia</atitle><jtitle>International Journal of Cardiovascular Imaging</jtitle><addtitle>Int J Cardiovasc Imaging</addtitle><date>2006-06-01</date><risdate>2006</risdate><volume>22</volume><issue>3-4</issue><spage>443</spage><epage>448</epage><pages>443-448</pages><issn>1569-5794</issn><eissn>1573-0743</eissn><coden>IJCIBI</coden><abstract>The outcome of cardiac sarcoidosis is sometimes very poor. Ventricular tachycardia (VT) associated with cardiac sarcoidosis is the most common cause of sudden death among most patients. However, there is no established method for potential VT in patients with cardiac sarcoidosis. Thus, we investigated the utility of evaluation of gallium-67 scintigraphy for potential VT in patients with cardiac sarcoidosis.
Cardiac sarcoidosis was diagnosed in 25 patients at ours or collaborating hospitals during the period 1982 through 2004. Twenty-one of these patients were treated with corticosteroid, and these patients were divided into two groups, depending on whether VT was present: a non-VT group (n=7) and a VT group (n=14). Laboratory and gallium-67 scintigraphy findings were examined in both groups. During the follow-up period, initial and maintenance dosages of corticosteroid did not differ significantly between the groups. Accumulation of gallium-67 in the heart at the time of diagnosis was detected more frequently in the VT group than in the non-VT group (14.3 vs. 71.4%, p<0.05). Six of the seven VT patients who underwent follow-up examination showed improvement on the scintigram obtained after treatment. Five of the six showed no VT recurrence in terms of Holter electrocardiogram, electrophysiologic study, or delivery of implantable cardioverter defibrillator shock. Serum angiotensin-converting enzyme and lysozyme concentrations were within normal limits in most patients in both groups.
Activity of sarcoid granulomas may be associated with the occurrence of VT. Gallium-67 scintigraphy reflects the activity of sarcoid granulomas and thus is useful for evaluation of cardiac sarcoidosis in patients with potential VT.</abstract><cop>United States</cop><pub>Springer Nature B.V</pub><pmid>16763884</pmid><doi>10.1007/s10554-005-9043-x</doi><tpages>6</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1569-5794 |
| ispartof | International Journal of Cardiovascular Imaging, 2006-06, Vol.22 (3-4), p.443-448 |
| issn | 1569-5794 1573-0743 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_68051658 |
| source | MEDLINE; Springer Nature |
| subjects | Adrenal Cortex Hormones - therapeutic use Amiodarone - therapeutic use Anti-Arrhythmia Agents - therapeutic use Anti-Inflammatory Agents - therapeutic use Cardiomyopathies - complications Cardiomyopathies - diagnostic imaging Cardiomyopathies - drug therapy Evaluation Studies as Topic Female Gallium Radioisotopes Humans Male Middle Aged Radionuclide Imaging Radiopharmaceuticals Retrospective Studies Sarcoidosis - complications Sarcoidosis - diagnostic imaging Sarcoidosis - drug therapy Tachycardia, Ventricular - diagnostic imaging Tachycardia, Ventricular - drug therapy Tachycardia, Ventricular - etiology Treatment Outcome |
| title | Utility of gallium-67 scintigraphy for evaluation of cardiac sarcoidosis with ventricular tachycardia |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-28T06%3A56%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Utility%20of%20gallium-67%20scintigraphy%20for%20evaluation%20of%20cardiac%20sarcoidosis%20with%20ventricular%20tachycardia&rft.jtitle=International%20Journal%20of%20Cardiovascular%20Imaging&rft.au=Futamatsu,%20Hideki&rft.date=2006-06-01&rft.volume=22&rft.issue=3-4&rft.spage=443&rft.epage=448&rft.pages=443-448&rft.issn=1569-5794&rft.eissn=1573-0743&rft.coden=IJCIBI&rft_id=info:doi/10.1007/s10554-005-9043-x&rft_dat=%3Cproquest_cross%3E1063783071%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=215628424&rft_id=info:pmid/16763884&rfr_iscdi=true |